» Articles » PMID: 11556937

Primary Care for Patients Infected with Human Immunodeficiency Virus: a Randomized Controlled Trial

Overview
Publisher Springer
Specialty General Medicine
Date 2001 Sep 15
PMID 11556937
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To measure the impact of a teaching intervention and to compare process and outcomes of care for HIV-infected patients randomly assigned to a general medicine clinic (GMC) or an infectious disease clinic (IDC) for primary care.

Design: Prospective, randomized, controlled trial.

Setting: University hospital in Durham, NC.

Patients: Two hundred fourteen consecutive HIV-infected patients presenting for primary care.

Intervention: Physicians at the GMC received HIV-related training and evidence-based practice guidelines.

Measurements: Utilization of services, health-related quality of life, preventive and screening measures, and antiretroviral use for one year.

Results: At baseline GMC patients were more likely to be African American (85% vs 71%; P =.03) and had lower baseline CD4+ cell counts than IDC patients (262 +/- 269 vs 329 +/- 275; P =.05). A similar and high proportion of patients in both groups received appropriate preventive care services including Pneumocystis carinii pneumonia (PCP) prophylaxis, pneumococcal vaccination, and antiretroviral therapy. Screening for TB was more frequent in GMC (89% vs 68%; P =.001). In the year following randomization, GMC patients made more visits to the emergency department than IDC patients (1.6 +/- 3.0 vs 0.7 +/- 1.5; P =.05). Hospital use was higher for GMC patients with average length of stay 7.8 +/- 6.3 days compared to 5.7 +/- 3.8 days for IDC patients (P =.01). In analyses, which adjust for potential baseline imbalances, these differences remained.

Conclusions: Targeted education in GMC achieved similar provision of primary care for GMC patients, yet use of health care services was higher for this group. The delivery of adequate primary care is necessary but not sufficient to produce changes in health care utilization.

Citing Articles

Clinical outcomes of HIV care delivery models in the US: a systematic review.

Kimmel A, Martin E, Galadima H, Bono R, Tehrani A, Cyrus J AIDS Care. 2016; 28(10):1215-22.

PMID: 27177151 PMC: 4972662. DOI: 10.1080/09540121.2016.1178702.


Identifying Best Practices for Increasing Linkage to, Retention, and Re-engagement in HIV Medical Care: Findings from a Systematic Review, 1996-2014.

Higa D, Crepaz N, Mullins M AIDS Behav. 2015; 20(5):951-66.

PMID: 26404014 PMC: 6719316. DOI: 10.1007/s10461-015-1204-x.


A population-based study comparing patterns of care delivery on the quality of care for persons living with HIV in Ontario.

Kendall C, Taljaard M, Younger J, Hogg W, Glazier R, Manuel D BMJ Open. 2015; 5(5):e007428.

PMID: 25971708 PMC: 4431060. DOI: 10.1136/bmjopen-2014-007428.


Review of Clinical Trials Testing the Effectiveness of Clinician Intervention Approaches to Prevent Sexually Transmitted Diseases in Adolescent Outpatients.

Boekeloo B, Griffin M Curr Pediatr Rev. 2015; 1(2):173-185.

PMID: 25657616 PMC: 4315618. DOI: 10.2174/1573396054065457.


Nurse versus doctor management of HIV-infected patients receiving antiretroviral therapy (CIPRA-SA): a randomised non-inferiority trial.

Sanne I, Orrell C, Fox M, Conradie F, Ive P, Zeinecker J Lancet. 2010; 376(9734):33-40.

PMID: 20557927 PMC: 3145152. DOI: 10.1016/S0140-6736(10)60894-X.


References
1.
. 1997 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: disease-specific recommendations. USPHS/IDSA Prevention of Opportunistic Infections Working Group. US Public Health.... Clin Infect Dis. 1997; 25 Suppl 3:S313-35. View

2.
. 1997 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. Ann Intern Med. 1998; 127(10):922-46. View

3.
Bozzette S, Berry S, Duan N, Frankel M, Leibowitz A, Lefkowitz D . The care of HIV-infected adults in the United States. HIV Cost and Services Utilization Study Consortium. N Engl J Med. 1998; 339(26):1897-904. DOI: 10.1056/NEJM199812243392606. View

4.
Gebo K, Chaisson R, Folkemer J, Bartlett J, Moore R . Costs of HIV medical care in the era of highly active antiretroviral therapy. AIDS. 1999; 13(8):963-9. DOI: 10.1097/00002030-199905280-00013. View

5.
Shapiro M, Morton S, McCaffrey D, Senterfitt J, Fleishman J, Perlman J . Variations in the care of HIV-infected adults in the United States: results from the HIV Cost and Services Utilization Study. JAMA. 1999; 281(24):2305-15. DOI: 10.1001/jama.281.24.2305. View